Oncologie
Toleranța la anemia normovolemică
Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients. (se deschide o fereastră nouă)
Sursă: Gynecol Oncol 2014;132(1):227-30.
Index: PubMed 24512847
DOI: 10.1016/j.ygyno.2013.10.019
https://www.ncbi.nlm.nih.gov/pubmed/24512847 (se deschide o fereastră nouă)
Liberal or restrictive transfusion in high-risk patients after hip surgery. (se deschide o fereastră nouă)
Sursă: N Engl J Med 2011;365(26):2453-62.
Index: PubMed 22168590
DOI: 10.1056/NEJMoa1012452
https://www.ncbi.nlm.nih.gov/pubmed/22168590 (se deschide o fereastră nouă)
Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (se deschide o fereastră nouă)
Sursă: Transfusion 2016;56(10):2438-42.
Index: PubMed 27385671
DOI: 10.1111/trf.13703
https://www.ncbi.nlm.nih.gov/pubmed/27385671 (se deschide o fereastră nouă)
Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (se deschide o fereastră nouă)
Sursă: J Clin Oncol 2015;33(15):1674-9.
Index: PubMed 25870085
DOI: 10.1200/JCO.2014.57.9912
https://www.ncbi.nlm.nih.gov/pubmed/25870085 (se deschide o fereastră nouă)
Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. (se deschide o fereastră nouă)
Sursă: Transfus Med Rev 2002;16(1):34-45.
Index: PubMed 11788928
https://www.ncbi.nlm.nih.gov/pubmed/11788928 (se deschide o fereastră nouă)
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (se deschide o fereastră nouă)
Sursă: N Engl J Med 1999;340(6):409-17.
Index: PubMed 9971864
DOI: 10.1056/NEJM199902113400601
https://www.ncbi.nlm.nih.gov/pubmed/9971864 (se deschide o fereastră nouă)
Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (se deschide o fereastră nouă)
Sursă: Intensive Care Med 2013;39(3):445-53.
Index: PubMed 23184038
DOI: 10.1007/s00134-012-2757-z
https://www.ncbi.nlm.nih.gov/pubmed/23184038 (se deschide o fereastră nouă)
How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (se deschide o fereastră nouă)
Sursă: Cancer Treat Rev 2016;46:1-8.
Index: PubMed 27046422
DOI: 10.1016/j.ctrv.2016.03.010
https://www.ncbi.nlm.nih.gov/pubmed/27046422 (se deschide o fereastră nouă)
Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. (se deschide o fereastră nouă)
Sursă: Transfusion 2014;54(10 Pt 2):2678-86.
Index: PubMed 25135770
DOI: 10.1111/trf.12825
https://www.ncbi.nlm.nih.gov/pubmed/25135770 (se deschide o fereastră nouă)
Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. (se deschide o fereastră nouă)
Sursă: J Clin Oncol 2020;38(13):1463-73.
Index: PubMed 32083994
DOI: 10.1200/JCO.19.01836
https://www.ncbi.nlm.nih.gov/pubmed/32083994 (se deschide o fereastră nouă)
Transfusion indications for patients with cancer. (se deschide o fereastră nouă)
Sursă: Cancer Control 2015;22(1):38-46.
Index: PubMed 25504277
https://www.ncbi.nlm.nih.gov/pubmed/25504277 (se deschide o fereastră nouă)
Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity. (se deschide o fereastră nouă)
Sursă: Am J Surg 2015;210(6):1197-204.
Index: PubMed 26602534
DOI: 10.1016/j.amjsurg.2015.08.013
https://www.ncbi.nlm.nih.gov/pubmed/26602534 (se deschide o fereastră nouă)